4.3 Article

Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade

Journal

CANCER CAUSES & CONTROL
Volume 27, Issue 8, Pages 1043-1047

Publisher

SPRINGER
DOI: 10.1007/s10552-016-0782-x

Keywords

Vessel morphology; Angiogenesis; Gleason grade; Prostate cancer mortality

Funding

  1. National Institutes of Health [PO1 CA055075, CA141298, CA13389, UM1 CA167552]
  2. US Army Prostate Cancer Research Program Idea Development Award [PC060389]
  3. DF/HCC Prostate SPORE Career Development Award NIH/NCI [P50 CA90381]
  4. Ohio State University NIH [P30 CA16058]

Ask authors/readers for more resources

Higher Gleason grade is associated with prostate cancer mortality; however, there is significant heterogeneity in this association. We evaluated whether vessel morphology, a biomarker of angiogenesis, aided in distinguishing mortality risks among men with high Gleason grading. We characterized vessel morphology (area and irregularity) among 511 patients diagnosed with prostate cancer during 1986 to 2000, re-reviewed Gleason grade, and followed men through 2012. Men were grouped according to integrated vessel lumen irregularity and vessel area across Gleason grade. The more angiogenic group was identified as those with more irregular vessel lumen and smaller vessel area. Crude rates (95 % confidence intervals) and survival probability were estimated across Gleason grade and vessel morphology. During a median 14-year follow-up, 62 men developed bone metastases or died of prostate cancer. Lethality rates were uniformly low within Gleason grade categories 6 and 7(3 + 4), regardless of vessel morphology. However, among men with Gleason grades of 7(4 + 3) or 8-10, the more angiogenic group was associated with fourfold higher risk of lethal outcomes compared to those with less angiogenic potential. Ten-year survival probability ranged from 95 to 74 % according to the extent of vessel morphology (p < 0.0001, log-rank test). Vessel morphology may aid Gleason grading in predicting prostate cancer mortality risks among men diagnosed with high-grade Gleason cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available